Ignite Creation Date:
2025-12-26 @ 2:42 PM
Ignite Modification Date:
2026-01-26 @ 11:18 AM
Study NCT ID:
NCT02382406
Status:
TERMINATED
Last Update Posted:
2023-05-23
First Post:
2015-02-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Carboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLC
Sponsor:
Nisha Mohindra, MD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-06-04
Start Date Type:
ACTUAL
Primary Completion Date:
2022-04-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-04-14
Completion Date Type:
ACTUAL
First Submit Date:
2015-02-24
First Submit QC Date:
None
Study First Post Date:
2015-03-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-07-07
Results First Submit QC Date:
None
Results First Post Date:
2022-10-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-19
Last Update Post Date:
2023-05-23
Last Update Post Date Type:
ACTUAL